The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Provides tools for simulating, monitoring, and evaluating Bayesian and adaptive clinical trial designs with binary outcomes. The package includes methods for trial simulation, posterior and predictive probability monitoring, adaptive randomization, Bayesian treatment-effect estimation, dose-finding designs, two-stage phase II trial designs, group sequential monitoring, operating-characteristic evaluation, interim analyses, and decision-support procedures. The methodological foundation includes the two-stage phase II design described by Simon (1989) <doi:10.1016/0197-2456(89)90015-9>.
| Version: | 0.1.2 |
| Imports: | stats, utils, dplyr, ggplot2, rlang |
| Suggests: | testthat (≥ 3.0.0) |
| Published: | 2026-07-30 |
| DOI: | 10.32614/CRAN.package.AdaptiveTrialsR |
| Author: | Muhammad Zahir Khan [aut, cre] |
| Maintainer: | Muhammad Zahir Khan <zahirstat007 at gmail.com> |
| BugReports: | https://github.com/zerish12/AdaptiveTrialsR/issues |
| License: | MIT + file LICENSE |
| URL: | https://github.com/zerish12/AdaptiveTrialsR |
| NeedsCompilation: | no |
| Materials: | README |
| CRAN checks: | AdaptiveTrialsR results |
| Reference manual: | AdaptiveTrialsR.html , AdaptiveTrialsR.pdf |
| Package source: | AdaptiveTrialsR_0.1.2.tar.gz |
| Windows binaries: | r-devel: AdaptiveTrialsR_0.1.2.zip, r-release: AdaptiveTrialsR_0.1.2.zip, r-oldrel: AdaptiveTrialsR_0.1.2.zip |
| macOS binaries: | r-release (arm64): AdaptiveTrialsR_0.1.2.tgz, r-oldrel (arm64): AdaptiveTrialsR_0.1.2.tgz, r-release (x86_64): AdaptiveTrialsR_0.1.2.tgz, r-oldrel (x86_64): AdaptiveTrialsR_0.1.2.tgz |
Please use the canonical form https://CRAN.R-project.org/package=AdaptiveTrialsR to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.